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Blunting of sympathetic vasoconstriction in exercising muscle is well-established.
Whether it persists during the early post-exercise period is unknown. This study tested
the hypothesis that it persists in human skeletal muscle during the first 10min of recovery
from exercise. Eight healthy young males (21.4 ± 0.8 yrs, SE) performed 7min of forearm
rhythmic isometric handgrip exercise at 15% below forearm critical force (fCF). In separate
trials, a cold pressor test (CPT) of 2min duration was used to evoke forearm sympathetic
vasoconstriction in each of Rest (R), Steady State Exercise (Ex), 2–4min Post-Exercise
(PEearly), and 8–10min Post-Exercise (PElate). A 7min control exercise trial with no CPT
was also performed. Exercising forearm brachial artery blood flow, arterial blood pressure,
cardiac output (CO), heart rate (HR), forearm deep venous catecholamine concentration,
and arterialized venous catecholamine concentration were obtained immediately prior to
and following the CPT in each trial. CPT resulted in a significant increase in forearm
venous plasma norepinephrine concentration in all trials (P = 0.007), but no change in
arterialized plasma norepinephrine (P = 0.32). CPT did not change forearm venous plasma
epinephrine (P = 0.596) or arterialized plasma epinephrine concentration (P = 0.15). As
assessed by the %reduction in forearm vascular conductance (FVC) the CPT evoked
a robust vasoconstriction at rest that was severely blunted in exercise (R = −39.9 ±
4.6% vs. Ex = 5.5 ± 7.4%, P < 0.001). This blunting of vasoconstriction persisted at
PEearly (−12.3 ± 10.1%, P = 0.02) and PElate (−18.1 ± 8.2%, P = 0.03) post-exercise.
In conclusion, functional sympatholysis remains evident in human skeletal muscle as
much as 10min after the end of a bout of forearm exercise. Persistence of functional
sympatholysis may have important implications for blood pressure regulation in the face
of a challenge to blood pressure following exercise.
Keywords: functional sympatholysis, skeletal muscle blood flow, sympathetic vasoconstriction, exercise, cold
pressor test
INTRODUCTION
During skeletal muscle exercise, increases in exercising skeletal
muscle vascular conductance paired with elevations in cardiac
output (CO) act to increase muscle oxygen delivery in order to
meet metabolic demand (Andersen and Saltin, 1985; Koskolou
et al., 1997). Although exercising skeletal muscle vascular con-
ductance increases, the magnitude of this increase appears to be
restrained by increases in sympathetic vasoconstrictor influence,
regardless of whether the exercise involves a small muscle mass
(Joyner et al., 1992) or a large muscle mass (Rowell, 1997). Both
baroreflex (Keller et al., 2004) and metaboreflex-mediated (Seals
and Victor, 1991) increases in muscle sympathetic nerve activity
(MSNA) can contribute to this sympathetic restraint. In the case
of large muscle mass exercise at higher intensities, this restraint
is believed to be essential for preventing skeletal muscle vasodila-
tion from exceeding CO and threatening arterial blood pressure
during exercise (Rowell, 1997; O’Leary et al., 1997).
WhileMSNA in exercisingmusclemaintains its effectiveness as
part of blood pressure regulation (Keller et al., 2004), the respon-
siveness of resistance vessels to it is blunted. This blunting was
first identified by Remensnyder et al. (1962) in an in situ animal
model and termed functional sympatholysis. Over the past ∼15
years, it has been clearly established that functional sympathol-
ysis occurs in exercising human skeletal muscle of both the arm
and leg (Hansen et al., 2000; Tschakovsky et al., 2002; Dinenno
et al., 2005; Watanabe et al., 2007; Fadel et al., 2012; Mortensen
et al., 2012; Saltin and Mortensen, 2012). Its magnitude increases
with exercise intensity, at least in the forearm (Tschakovsky et al.,
2002; Watanabe et al., 2007).
Whether such blunting of sympathetic vasoconstriction per-
sists following exercise, and if so for how long, has received
less attention. DiCarlo’s group has explored this in rabbit and
rodent exercise studies and identified that between 10 and 26min
post-exercise blunted vasoconstriction in response to the α1-
receptor agonist phenylephrine remained in evidence (Howard
and DiCarlo, 1992; Patil et al., 1993). In humans, Halliwill and
colleagues have investigated the role of sympathetic vasomotor
control in explaining the post-exercise hypotension and increased
resting vasodilation in the exercised muscles that persists for a
number of hours following cycling exercise (Halliwill et al., 1996,
2003). Their first study identified a decrease in MSNA at rest
and in response to a hypotensive challenge (sodium nitroprusside
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bolus infusion) ∼60min post-exercise, as well as a reduced calf
vasoconstrictor response per unit MSNA increase evoked by
ischemic forearm exercise ∼90min post-exercise (Halliwill et al.,
1996). Their second study identified intact sympathetic vasocon-
striction in the exercised legs in response to infusion of selective
α1 and α2 agonists ∼60min following cycling exercise (Halliwill
et al., 2003).
To our knowledge, these are the only studies to date which have
investigated impaired post-exercise sympathetic vasoconstriction
in humans. The current interpretation of their findings is that in
humans the impaired transduction of MSNA to vasoconstriction
an hour or more after exercise is due to pre-junctional not post-
junctional (α receptor response) mechanism(s). Since functional
sympatholysis during exercise has repeatedly been demonstrated
to be a post-junctional phenomenon in humans (Rosenmeier
et al., 2003; Dinenno et al., 2005; Kirby et al., 2008) blunted
transduction of MSNA to vasoconstriction so long after exer-
cise cessation may represent a delayed alternate “sympatholytic”
mechanism.
To date, blunting of sympathetic vasoconstriction during the
very early post-exercise recovery period (0–10min) has not been
investigated in humans. This is likely because quantification
of sympathetic vasoconstriction during the non-steady state of
exercise recovery is problematic. Potential mechanisms of func-
tional sympatholysis include NO and Prostaglandins (Thomas
and Victor, 1998; Chavoshan et al., 2002; Dinenno and Joyner,
2004), ATP (Rosenmeier et al., 2004; Kirby et al., 2008) and most
recently metabolic acidosis (Ives et al., 2012). Of these, only NO’s
role in elevated skeletal muscle blood flow immediately post-
exercise (Shoemaker et al., 1997; Radegran and Saltin, 1999) has
been explored, with findings suggesting that it is a contributor.
However, elevated plasma [ATP] during (Gonzalez-Alonso et al.,
2002) and acutely following (Yegutkin et al., 2007) exercise, as
well as a sustained reduction in venous effluent pH for a num-
ber of minutes following intense exercise have also been observed
(Wiltshire et al., 2010). This would suggest that persistence
of functional sympatholysis during the immediate post-exercise
period is plausible in humans. The inevitable decline in sympa-
tholytic molecules might dictate the time course of diminishing
functional sympatholytic potency.
Therefore, we developed and validated a curve-fitting
approach to allow quantification of sympathetic vasoconstriction
in the immediate post-exercise non-steady state. We used this
to test the hypothesis that functional sympatholysis persists in





Originally, 10 healthy males [age = 21.4 ± 0.8 years (mean
± SE)] volunteered to participate in this study. Data from
two had to be omitted from final analysis due to issues dis-
cussed later. Therefore, data analysis and interpretation was
based on an n = 8. They were non-obese, non-smokers, nor-
motensive, and had similar physical activity levels as they com-
monly engaged in moderate bouts of walking, intramural sports,
and occasional full body workouts (Table 2). This experiment
was approved by the Queen’s University Health Sciences and
Affiliated Teaching Hospitals Research Ethics Board, in compli-
ance with the terms of the Declaration of Helsinki. After receiving
a complete verbal and written description of the experimen-
tal protocol and associated potential risks, each subject pro-
vided written, informed consent to participate in the outlined
experiment.
Maximum voluntary contraction (MVC)
Maximum voluntary contraction (MVC) strength for each sub-
ject was determined as the peak force in kg of three 1–2 s maximal
isometric handgrip contractions while laying supine with the arm
extended to the side at heart level. Each contraction was fol-
lowed by 1min of recovery prior to the next contraction. Subjects
were instructed to recruit only the forearm muscles during the
voluntary contraction, so that the MVC performed would be rep-
resentative of forearm handgrip strength in the position that was
used for the experimental exercise protocol.
Forearm critical force (fCF) exercise test
Each subject underwent a single bout forearm critical force (fCF)
exercise test in order to determine the work rate they would exer-
cise at during the forearm exercise protocol. The fCF exercise
task consisted of 10min of rhythmic isometric maximal forearm
handgrip contractions at a duty cycle of 1:2 s (1 s contraction,
2 s relaxation) with the handgrip dynamometer. The force out-
put from the dynamometer and the contraction duty cycle were
displayed to the subject throughout the exercise test. The subject
was instructed to attempt to reach their MVC force output on
each contraction over the 10min. Each participant’s fCF was cal-
culated as the average power output of the last 30 s of the exercise
test(Kellawan et al., 2010).
The fCF is the highest exercise intensity at which a metabolic
steady state (plateau of VO2 and high energy phosphates) still
occurs (Poole et al., 1988; Jones et al., 2008). As such, it repre-
sents a “functional peak aerobic power,” as it is the highest exercise
intensity that can be maintained via aerobic ATP production
without requiring supplemental ATP production via substrate
level phosphorylation. It is commonly described as the boundary
between heavy and severe exercise (Vanhatalo et al., 2007).
Forearm exercise at 15% below forearm critical force
Forearm exercise designed to evoke forearm functional sym-
patholysis consisted of 7min of rhythmic isometric forearm
handgrip contractions at a duty cycle of 1.2 s at 15% below
the subject’s fCF. This exercise intensity was chosen to maxi-
mize the potential for functional sympatholysis since it is exercise
intensity-dependent (Tschakovsky et al., 2002), while still achiev-
ing a steady state exercise response (Moritani et al., 1981; Jones
et al., 2008). As the active muscle mass is small, a central cardio-
vascular challenge was not expected while investigating the local
vascular phenomenon of functional sympatholysis. The target
force of 15% below fCF was displayed on the feedback moni-
tor during the task. The exercise task was followed by 15min of
supine recovery.
Cold pressor test (CPT)
In this study, activation of sympathetic vasoconstriction with the
subject laying supine was evoked using a CPT. The CPT required
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the subject to place a foot into a prepared ice bath (0–3◦C)
for 2min. Subjects were instructed to rest their foot at the bot-
tom of the ice bath, remain relaxed, avoid tensing their muscles,
and concentrate on their breathing to maintain a normal breath-
ing pattern rather than holding their breath at any time during
the CPT.
Arterialized blood sampling for catecholamines
Subjects had their right hand heated with a standard 50W heat-
ing pad (Sunbeam, Jarden Consumer Solutions, Canada) for
∼10min. Following hand heating, a 1-mL venous blood sample
was taken from a dorsal hand vein or superficial vein of the wrist
with an appropriately positioned butterfly needle (retrograde) or
20-gauge intravenous catheter (antegrade). The use of venous
blood samples obtained from a heated vein has been previously
demonstrated to accurately reflect the arterial concentration of
lactate (Zavorsky et al., 2005). Thus, it was expected that other
arterial plasma constituents, such as catecholamines, would also
be representative.
The collected blood sample was immediately analyzed
(StatProfile M Blood Gas Analyzer; Nova Biomedical,
Mississauga, ON) to determine the hemoglobin oxygen sat-
uration (%SO2). Adequate arterialization was defined as greater
than 90% SO2. If appropriate arterialization was not achieved,
further hand heating and subsequent blood sampling was
required until a sample with SO2 of greater than 90% was
obtained. When this was confirmed, a blood sample of 3mL
was initially drawn and discarded, followed by two 6mL blood
samples collected into EDTA vacutainer tubes.
Forearm deep venous blood sampling for catecholamines
A 20-guage catheter was inserted retrograde into an antecubital
vein of the participant’s right arm (non-experimental arm). Echo
ultrasound was utilized prior to catheterization in order to ensure
the selected vein drained forearm muscle (cephalic or median
cubital vein) and was not a superficial vein.
Venous blood samples were drawn immediately pre- and post-
CPT in order to assess the forearm catecholamine response to the
CPT. Samples were withdrawn from the non-exercising arm as the
sympathetic neural activation due to the CPT would be the same
for both arms, and the right arm would not have the confound of
different blood flows between rest, exercise and recovery. A blood
sample of 3mLwas initially drawn and discarded, followed by two
6mL blood samples collected into EDTA vacutainer tubes at each
sample period.
Central hemodynamic monitoring
Heart rate (HR) was measured beat-by-beat with an electro-
cardiogram 3-lead placement. Arterial blood pressure for the
determination of mean arterial pressure (MAP) was measured
continuously throughout the study via finger photoplethysmog-
raphy (Finometer MIDI, Finapres Medical Systems, Amsterdam,
Netherlands) on a finger of the non-exercising hand. Stroke
volume (SV) was estimated from the blood pressure waveform
(Beatscope EasyModelFlow™method, FinapresMedical Systems,
Amsterdam, Netherlands) and the same software calculated CO as
HR × SV.
Brachial artery diameter and mean blood velocity (MBV)
For the left arm which was used to perform the exercise (exper-
imental arm), the brachial artery was imaged through the
use of a linear 10MHz echo ultrasound probe, operating in
two-dimensional B-mode (Vingmed System FiVe; GE Medical
Systems, London, ON). MBV was measured with a 4MHz
pulsed Doppler ultrasound probe (Model 500V TCD; Multigon
Industries, Mt. Vernon, NY), which was secured to the skin at a
location ∼5–10 cm distal to the Echo probe and proximal to the
antecubital fossa. This position was marked on the skin to ensure
the same probe position for experimental trials occurring on sep-
arate days. MBV was measured and recorded continuously on a
personal computer data acquisition system. The probe insonation
angle when parallel to the artery was 57◦. The insonation angle
was corrected based on imaging the vessel orientation relative to
the skin surface at the Pulsed Doppler probe site. This correction
adjusts the mean blood velocity voltage output that was calibrated
at the probe insonation angle. For details see Pyke et al. (2008).
SUBJECT SCREENING AND FAMILIARIZATION
Subjects were instructed to abstain from consuming alcohol
and/or caffeine 12 h prior and any food 4 h prior to the screen-
ing trial. Each subject participated in an fCF test, and practiced
the constant work rate forearm exercise to become familiar with
the exercise and be able to perform consistent contractions. In
addition, each subject participated in the following screening
activities.
7-day physical activity recall questionnaire (7-PAR)
Each subject completed a 7-PAR during the initial screening and
familiarization visit to the laboratory. The 7-PAR was used to
characterize their average level of physical activity prior to com-
pleting the study. The use of the 7-PAR has previously been
demonstrated as a reliable and valid method of quantifying
physical activity (Taylor et al., 1984; Dishman and Steinhardt,
1988).
Echo and Doppler ultrasound screening
Initial echo and pulsed Doppler ultrasound screening of the sub-
ject’s experimental arm was necessary in order to ensure that
a clear artery image and a blood velocity signal which did not
contain signal from veins adjacent to the brachial artery could
be obtained at rest, during and after forearm exercise. Subjects
were instructed to lay supine on the laboratory bed while the
investigator obtained a brachial artery image and brachial artery
blood velocity signal as previously described. The subject then
performed submaximal intensity rhythmic forearm handgrip
contractions for a few minutes during which signal quality was
assessed. No prospective subjects were turned away due to a poor
brachial artery image or blood velocity signal.
CPT screening
Since the assessment of functional sympatholysis requires an
experimental manipulation that elevates sympathetic vasocon-
striction, it was necessary to select subjects in which a sympa-
thetic vasoconstrictor response to the CPT could be confirmed.
Therefore, all interested subjects completed CPT screening in
order to confirm that the pressor response to the CPT was
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primarily due to increased TPR (which indicates sympathetic
vasoconstrictor activation) rather than elevations of CO. The out-
lined CPT screening protocol was repeated approximately 3–4
months following the initial screening visit in order to determine
the repeatability of each participant’s response to the CPT. Of the
27 interested in participating, 24 returned to the laboratory for a
follow-up screening. Of these 24 individuals, 10 demonstrated a
clear, consistent TPR response to the CPT. These TPR responders
were the final subjects selected to participate in the experiment.
Of these 10, two were not included in data analysis; one due to
poor quality Doppler velocity signal and the other due to lack of
vasoconstrictor response to CPT. Therefore, an n = 8 was used
for data analysis.
EXPERIMENTAL PROTOCOLS
Subjects came to the laboratory on three separate days for three
separate experimental protocols having abstained from consum-
ing alcohol and/or caffeine for at least 12 h and food for at least
4 h. They were instructed to lie supine on the laboratory bed
with both arms supported to the side at heart level and instru-
mented for data collection while resting quietly. The experimental
protocols were designed to assess functional sympatholysis dur-
ing exercise (Ex), at 4min post-exercise (PEearly), and at 10min
post-exercise (PElate). Each of these protocols consisted of three
different experimental trials (Figure 1). The first trial was always a
resting CPT trial (A in Figure 1) which consisted of 2min resting
baseline, followed by 2min of the CPT, and finally another 2min
post-CPT. The second trial was either a control exercise trial (B
in Figure 1), consisting of 2min resting baseline, followed by
7min forearm exercise at 15% below fCF, and finally 10min of
post-exercise recovery, or a CPT trial (one of either exercise CPT,
PEearly CPT or PElate CPT (C–E in Figure 1). The order in which
a subject performed trial B vs. either of C, D, or E was consistent
across protocols within subjects, but counter-balanced between
subjects. For example, one subject may have performed trials on
the three different days in the order A, B, C and therefore the other
days would be A, B, E and A, B, D. Another may have performed
them in order A, C, B and therefore the other days would be A,
D, B and A, E, B. Each experimental trial was separated by at
least 10min of recovery in order to allow variables to return to
baseline values. As there were two CPT’s within each experimen-
tal protocol, the subject alternated the foot that was placed in the
ice bath.
In order to confirm that the vasoconstrictor response to a
second CPT was not blunted, we performed additional time
control experiments (n = 7) in which a CPT was administered
twice under resting conditions in one laboratory visit. The time
between the two CPT tests was equivalent to the time interval that
would have occurred between the rest CPT and half way between
the time of the PEearly and PElate CPT’s.
FIGURE 1 | Schematic depicting the different experimental trials and
the timing of blood samples and the CPT for each. BLN, resting
baseline. CPT, 2min Cold pressor test. (A) CPT during rest. (B)
Exercise trial without CPT. (C) CPT during exercise. (D) CPT at
2–4min of the post-exercise period. (E) CPT at 8–10min of the
post-exercise period.
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DATA ACQUISITION AND ANALYSIS
Central hemodynamic response to CPT
For all trials shown in Figure 1, central hemodynamic mea-
surements were recorded continuously for the duration of each
trial at 200Hz using a Powerlab™ data acquisition system
(ADInstruments, Sydney, Australia). To quantify the effect of the
CPT on central hemodynamics and confirm that it was consistent
across days, beat-by-beat measurements of mean arterial blood
pressure (MAP), and calculated CO and TPR (MAP/CO) during
the rest trial on the PEearly and PElate days were averaged over 30 s
at the following time points: baseline immediately prior to start
of CPT, and 30, 60, 90, and 120 s of the CPT.
Forearm hemodynamic response to CPT
Brachial arterymean blood velocity (MBV).Brachial arteryMBV
was recorded continuously for the duration of each trial at 200Hz
using a Powerlab™ data acquisition system (ADInstruments,
Sydney, Australia). Brachial artery MBV for the purpose of assess-
ing the forearm hemodynamic response to CPT at rest and during
exercise was the average MBV over the 30 s period immediately
prior to the start of the CPT and the last 30 s of the CPT. For the
post-exercise period the continuous measures of MBV were used
in conjunction with brachial artery diameter (see below) to obtain
a continuous FBF profile post-exercise.
Brachial artery diameter (BAD). Brachial artery images were
recorded continuously in Digital Imaging and Communications
inMedicine (DICOM) format and stored on a personal computer
for offline analysis. BADwas analyzed via custom built automated
edge-detection software (Woodman et al., 2001), which allows
the user to identify a region of interest where the vessel walls are
the clearest. The arterial walls are then tracked by detecting the
greatest change in pixel brightness in the vertical axis. The edge-
detection software collects one diameter measurement for every
pixel column and uses the median diameter as the diameter for
that frame.
With this approach, brachial artery diameter measurements
for the purpose of assessing the forearm hemodynamic response
to CPT at rest and during exercise were obtained at 5 s increments
over the 30 s period immediately prior to the start of the CPT and
the last 30 s of the CPT. These 5 s increment measurements were
averaged to obtain a single diameter measurement that was used
with the corresponding MBV to calculate FBF for rest and exer-
cise pre- and end-CPT, respectively. For post-exercise, diameter
measurements were obtained every 20 s. These were then curve
fit (mono-exponential decay) with statistical software (SigmaPlot
11.0, Systat Software, Inc.) to provide a continuous diameter esti-
mate and allow forearm blood flow calculations for the entire
recovery period.
Forearm blood flow (FBF). FBF (ml/min) was calculated as fol-
lows: FBF = [MBV × 60 × π× (BAD/2)2], where MBV is cm/s,
60 is s/min, BAD is cm.
In the case of the Rest and Exercise CPT experimental tri-
als, where there is a steady state in the absence of CPT, FBF
was derived from the 30 s averaged MBV and brachial artery
diameter at the pre- and end-CPT time points. In this way,
CPT-evoked sympathetic vasoconstriction is derived by compar-
ing pre- and end-CPT time points. In the case of the Post-Exercise
CPT experimental trials, the curve fit of the diameter measure-
ments provided beat-by-beat diameter values corresponding to
the beat-by-beat MBV, allowing beat-by-beat FBF calculation (see
below for explanation of analysis required for quantifying CPT-
evoked sympathetic vasoconstriction during the non-steady state
post-exercise period).
Forearm vascular conductance (FVC). FVC (ml/min/100
mmHg) was calculated as follows: FVC = FBF/MAP × 100,
where MAP is mmHg and multiplying by 100 just allows FVC
values to be in the same order of magnitude as FBF.
Sympatholysis during rest and exercise. In the case of the
Rest and Exercise CPT experimental trials, where there is a
steady state in the absence of CPT, FVC was derived from the
30 s averaged FBF and MAP at the pre- and end-CPT time
points. The vasoconstrictor effect of the CPT in the experimen-
tal forearm in these trials was calculated as the %reduction in
FVC = [(FVCpost-CPT − FVCpre-CPT)/FVCpre-CPT] × 100, where
FVCpost-CPT is the FVC averaged over the last 30 s of the CPT and
FVCpre-CPT is the FVC averaged over the 30 s immediately prior
to the CPT. A blunting of the %reduction in FVC in response
to the CPT during exercise compared to rest was interpreted as
representing functional sympatholysis (Tschakovsky et al., 2002).
Sympatholysis during post-exercise recovery. In the case of the
Post-Exercise CPT experimental trials, beat-by-beat FBF obtained
as described previously, was combined with beat-by-beat MAP
to obtain beat-by-beat FVC = FBF/MAP × 100 for the entire
recovery period. There is no steady-state FBF, FVC, or MAP in
the absence of CPT during the post-exercise recovery phase since
these are changing over time as a function of normal recovery
from exercise. Therefore, one cannot use a pre- vs. end-CPT com-
parison to quantify the CPT vasoconstrictor effect. To overcome
this, we developed an analysis approach that allowed us to deter-
mine what the FVC would have been during the last 30 s of the
CPT if the CPT had not occurred (i.e., FVCpredicted; what the nor-
mal recovery FVC at that time would have been). The difference
between this and the actual FVC (FVCactual) in the last 30 s of
the CPTwould therefore constitute the degree of vasoconstriction
evoked by the CPT during recovery from exercise.
To obtain this FVCpredicted the beat-by-beat post-exercise FVC
data was averaged into 3 s bins and curve fit using a mono-
exponential decay model (Sigmaplot 11.0, Systat Software Inc.),
with the CPT data removed. This curve fit then provided an esti-
mate of what FVC would have been during the time at which
the last 30 s of the CPT was occurring. We validated this anal-
ysis approach as follows. We used the 3 s averaged post-exercise
FVC from the control trials (no CPT administered), with a 2min
section of data corresponding to the timing of the CPT in the cor-
responding post-exercise CPT trials removed. We curve fit these
data and compared the curve fit values averaged over the last
30 s of this 2min period with the 30 s average of the actual FVC
(FVCactual) (see Figure 2 and Table 2) to ensure that the curve fit
approach provided valid estimates of FVCactual.
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FIGURE 2 | Examples of curve fit estimation of post-exercise forearm
vascular conductance (FVC). Panels (A) and (C) examples of individual
subject beat-by-beat post-exercise FVC responses during Control trials (see
Figure 1). White circles represent the beat-by-beat FVC data that is removed
during the curve fitting to mimic the curve fitting procedure during an actual
PEearly and PElate CPT trial. Gray circles represent the beat-by-beat FVC data
that is curve fit. Solid line is the curve fit. Panels (B) and (D) examples of
individual subject beat-by-beat post-exercise FVC responses during a PEearly
and PElate trial respectively (see Figure 1). White circles represent the
beat-by-beat FVC data that is removed during the curve fitting to allow curve
fit estimation of what FVC would have been without the CPT. Gray circles
represent the beat-by-beat FVC data that is curve fit. Solid line is the curve fit.
The degree of vasoconstriction due to the CPT in the PEearly
and PElate CPT trials was then calculated as %reduction in FVC=
[(FVCactual – FVCpredicted)/FVCpredicted] × 100, where FVCactual
was the average of the FVC during the last 30 s of the CPT and
FVCpredicted was the curve fit estimate of what FVC would have
been at that time in the absence of the CPT.
CPT catecholamine response: blood sample acquisition
For each experimental trial in which a CPT was performed 6mL
venous blood samples were obtained from the non-exercising
(right) arm for 10 s 1–2min prior to the CPT and immediately
after the end of the CPT. After being drawn, blood samples were
immediately centrifuged at 1500 Gs for 10min in a refrigerated
centrifuge at 4◦C. Plasma was separated from each sample and
pipetted into separate 1.5mL Eppendorf tubes. Plasma samples
were immediately stored in a –80◦C freezer for catecholamine
analysis. Norepinephrine [NE] and Epinephrine [Epi] were ana-
lyzed at a later date with a 2-CAT ELISA—Fast Track (Rocky
Mountain Diagnostics Inc., Colorado Springs, CO).
STATISTICAL ANALYSIS
The data collected from two subjects were omitted prior to sta-
tistical analysis. For one subject this was due to poor data quality
(MBV and brachial artery diameter measurements) during data
collection. For the other subject, analysis revealed that the CPT
did not evoke any forearm vasoconstriction in the Rest CPT trial.
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Since the CPT was used as a tool to evoke forearm sympathetic
vasoconstriction in order to determine if this vasoconstriction
was blunted under exercise and post-exercise conditions, fail-
ure to evoke vasoconstriction meant that we did not create the
required experimental conditions, and justified removal of the
subject. As a result, statistical analysis was performed on a total
of 8 subjects. All values are reported as means ± SE and sig-
nificance was set at P < 0.05 for all statistical analysis. For all
multiple comparison analysis, significant interactions or main
effects were analyzedwith a Student-Newman-Keuls post-hoc test.
All data analysis was completed with standard statistical software
(SigmaPlot 12.3, Systat Software, Inc.).
FVCpredicted vs. FVCactual
To assess the agreement between the curve fit derived FVCpredicted
vs. the FVCactual during the PEearly and PElate time points in
Control trials, we calculated a coefficient of variation between
these for each subject within each of the PEearly and PElate time
points and an intraclass correlation coefficient. In addition, we
plotted a linear regression of FVCpredicted (x-axis) vs. FVCactual
(y-axis) in order to determine if the relationship between the two
was on the line of identity, or if a correction factor for conversion
of FVCpredicted to FVCactual was required.
CPT activation repeatability
To confirm that the CPT evoked the same systemic response
across experimental days, a Two-Way repeated-measures ANOVA
(Time within CPT test, Day of CPT test) was performed on
MAP, CO, and TPR. Furthermore, to confirm the CPT evoked
the same forearm vasoconstriction between two trials on the same
day, as occurred on each experimental day, a Two-Way repeated-
measures ANOVA (Time within CPT test, Trial of CPT test) was
performed on FVC, and a One-Way repeated-measures ANOVA
was performed on the %change in FVC between trials.
Catecholamine response
To test the hypothesis that the CPT elevated forearm venous
plasma catecholamine concentration similarly in all experimental
trials, a Two-Way repeated-measures ANOVA was used to deter-
mine the main effect of Trial (Rest, Exercise, PEearly, and PElate)
and measurement Time (“Pre-CPT” and “Post-CPT”) and inter-
action effects of Trial × Time. A One-Way repeated-measures
ANOVA was used to compare the TIME (“Pre-CPT” and “Post-
CPT”) measurements of NE and Epi from arterialized venous
samples during the Rest trial to test the hypothesis that CPT did
not alter arterial catecholamine concentration.
Sympathetic vasoconstriction response to CPT
To test the hypothesis that there was a main effect of trial on
the reduction in FVC during the CPT, a One-Way repeated-
measures ANOVA was utilized to compare the TRIAL (Rest,
Exercise, PEearly, PElate) measurements of %change in FVC from
pre- to end-CPT.
RESULTS
Subject and 15% below foerearm critical force exercise character-
istics are presented in Table 1.
Table 1 | Subject characteristics.
N = 8
Age (years) 21.4 ± 0.8
Height (cm) 179.8 ± 1.3
Weight (kg) 80.3 ± 3.3
Forearm circumference (cm) 25.9 ± 0.5
Forearm volume (mL) 1125.0± 49.3
Energy expenditure (METS) 261.0 ± 11.6
Maximal voluntary contraction (kg) 56.4 ± 4.4
Forearm critical force (kg) 29.4 ± 2.4
Exercise at 15% below forearm critical force (kg), 25.0 ± 2.1,
(%MVC) 44.9 ± 2.9
Values are means ± S.E. METS—metabolic equivalents. Exercise at 15% below
forearm critical force is reported in kg and as a % of maximal voluntary
contraction (MVC).
CURVE FITTING TECHNIQUE FOR ESTIMATING FVCPREDICTED
Figures 2A,C provide an example from one subject of the curve
fit approach applied to the control trial post-exercise period that
was used to determine the ability for the curve fit to predict where
FVC would have been during a normal recovery. The data during
the time period where the 2min CPT would have occurred in the
PEearly and PElate CPT trials were removed from the post-exercise
period of the control trials for that day and then the curve fitting
was done, as would be the case during the actual PE CPT trials.
Table 2 presents the agreement between the curve fit predicted
FVC and the actual FVC during the last 30 s of this 2min period.
The validity of this curve fit approach for estimating what FVC
would have been in the last 30 s of the 2min CPT period is evi-
denced by the low coefficient of variation across subjects, the large
ICC (0.99 for PEearly day, 0.95 for the PElate day) and the lack of
difference between the average of the FVCactual and FVCpredicted.
Figure 3 shows that for the PEearly protocol control trials, a
regression of the FVCpredicted vs. FVCactual values was virtually
identical to the line of identity. For the PElate control trials the
FVCpredicted vs. FVCactual values, although very highly correlated,
were represented by a regression that was different from the line
of identity. However, on evaluation with a Cook’s distance test
to assess whether a data point has a disproportionately influential
effect on the regression parameters (indicated by a Cook’s d-value
greater than 1), we identified one data point with a Cook’s d-value
of 1.6 (Figure 3). This data point was subsequently omitted from
the regression, and the regression then was virtually identical to
the line of identity, indicating that our approach provided valid
FVCpredicted.
Figures 2B,D provide an example from one subject of the
curve fit approach applied to the PEearly and PElate CPT trials.
The curve fit was performed on the data with the CPT section
of data removed. The comparison between the curve fit and the
actual FVC data in the last 30 s of the CPT was used to quantify
the magnitude of vasoconstriction.
HEMODYNAMIC RESPONSE TO THE CPT
Table 3 presents the absolute values for HR, MAP, FBF, and FVC
for each exercise and post-exercise trial and time point. Figure 4
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Table 2 | FVCactual and FVCpredicted for control trials in PEearly and PElate protocols.
Subject Control trial PEearly Control trial PElate
FVCactual FVCpredicted CV (%) FVCactual FVCpredicted CV (%)
(ml/min/100mmHg) (ml/min/100mmHg)
B 430.6 422.2 1.4 91.7 114.9 15.9
I 131.7 96.5 21.8 102.1 100.8 0.9
K 288.5 249.6 10.2 46.2 49.4 4.6
L 64.7 60.3 5.0 72.0 69.7 2.3
T 103.1 114.2 7.2 67.2 52.7 17.1
V 30.1 36.2 13.1 23.5 22.3 3.6
W 213.6 217.3 1.2 56.0 61.7 6.9
AA 55.5 52.9 3.3 32.5 29.4 7.1
Mean 164.7 ± 48.8 156.2± 46.8 7.9 ±2.5 61.4 ± 9.7 62.6± 11.4 7.3 ±2.1
Mean ± SE. Control trial PEearly and PElate, refer to the time during the post-exercise period of the Control trial (B in Figure 1) at which the FVCactual and the
FVCpredicted from the curve fitting procedure (see Figures 2A,C) were obtained. CV—within-subject coefficient of variation.
presents the systemic hemodynamic response to the CPT at rest
for both the PEearly and PElate days. TheCPT resulted in a progres-
sive increase in MAP (main effect of time, P < 0.001) but there
was no difference between days (main effect of day, P = 0.727).
The same comparisons for TPR revealed a main effect of time
(P < 0.001) such that TPR decreased during the first 30 s of CPT
compared to pre-CPT and then progressively increased above
this nadir over the course of the CPT, such that it was signif-
icantly greater than pre-CPT at 90 and 120 s (both P = 0.02).
This response was consistent between days (main effect of day,
P = 0.801). Lastly, the same comparisons for CO revealed main
effect of time (P < 0.001). CO was elevated by 30 s of CPT fol-
lowed by a steady decline over the rest of the CPT, although
it was still significantly elevated compared to pre-CPT at the
end of CPT (P = 0.02). Again, there was no main effect of day
(P = 0.595).
CATECHOLAMINE RESPONSE TO THE CPT
The response of venous plasma [NE] and [Epi] concentration to
the administered CPT is portrayed in Figure 5. The CPT resulted
in a significant rise in forearm deep venous plasma [NE] for all
trials (main effect Pre- to End-CPT P = 0.001) and there was
no interaction effect (P = 0.777). One-Way repeated-measures
ANOVA comparison of the increase in venous plasma [NE]
between rest, exercise, PEearly, and PElate indicated no difference
(P = 0.500). There was no significant increase (P = 0.32) in the
arterialized plasma [NE] response to the CPT assessed during the
Rest trial. The arterialized plasma [Epi] concentration did not
change with CPT (P = 0.152), nor did the forearm deep venous
plasma [Epi] concentrations (Main effect of Pre- to End-CPT P =
0.595). However, there was an interaction between trial and Pre-
to End-CPT such that the Pre-CPT during Exercise was greater
than Rest (P = 0.004), PEearly (0.007), and PElate (P = 0.002).
FOREARM VASOCONSTRICTOR RESPONSE TO THE CPT
Figure 6 presents the vasoconstrictor response to CPT as
%change FVC. All subjects demonstrated a severely blunted to
completely abolished vasoconstriction when CPT was adminis-
tered during exercise. In contrast, 6 of 8 subjects in PEearly and 5 of
8 subjects in PElate still demonstrated a blunted vasoconstriction.
At the group level, a One-Way repeated-measures ANOVA and
subsequent post-hoc analysis identified that all trials were signifi-
cantly different from rest (Exercise: P < 0.001, PEearly: P = 0.022,
PElate: P = 0.032).
While P-values for the comparison of PEearly vs. Exercise and
PElate vs. Exercise were 0.073 and 0.052, respectively and therefore
did not reach the a priori 0.05 threshold for accepting that the dif-
ferences are not likely to be due to chance, the inadequate power
of the study to detect these differences must be considered when
interpreting the data.
TIME CONTROL EXPERIMENT FOREARM VASOCONSTRICTOR
RESPONSE TO CPT
Figures 7A,B present the vasoconstrictor response to CPT at rest
for two trials, used to confirm that the vasoconstrictor response
to a second CPT trial on a given day was maintained. There was
no main effect of trial (i.e., Pre- and End-CPT FVC was not dif-
ferent between trials, P = 0.271), but there was a main effect
of time (i.e., End-CPT FVC was less than Pre-CPT, P = 0.002).
Furthermore, the %reduction in FVC in CPT 1 vs. CPT 2 was not
different (P = 0.405).
DISCUSSION
This study was the first to test the hypothesis that functional
sympatholysis persists in human skeletal muscle in the imme-
diate (10min) post-exercise period. Functional sympatholysis is
a blunting of sympathetic vasoconstriction due to mechanisms
activated within skeletal muscle as a consequence of muscle con-
tractions. The nature of these mechanisms means that they would
not disappear immediately with cessation of muscle contractions
as their presence is not contingent on the mechanical or muscle
activation aspects of muscle contraction which disappear imme-
diately at end exercise. We have therefore termed the blunted
sympathetic vasoconstriction in the first 10min of exercise as a
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FIGURE 3 | Regression plots of the curve fit estimated forearm vascular
conductance (FVC) and the actual FVC during the last 30 s of the 2min
period in the control post-exercise condition coincident with the
timing of the CPT. Line of identity represented by dotted line. Regression
represented by solid line. Panel (A) regression for the PEearly CPT timing.
Panel (B) regression for the PElate CPT timing. One subject data point (gray
symbol) was excluded from the regression as it had a Cook’s d -value of 1.6,
indicating it had disproportionate impact on the regression parameters.
persistence of functional sympatholysis rather than referring to it
as a separate sympatholytic phenomenon.
The primary findings of this study were as follows. First, assess-
ment of the central hemodynamic response to CPT in the Rest
trial on each of the two post-exercise testing days (PEearly and
PElate) confirmed the repeatability of the CPT effect between days.
Namely, an initial CO-mediated pressor response transitioned
into continued increases in MAP resulting from increasing TPR
while CO was declining. When taken together with observations
of a robust forearm vasoconstriction at rest, and elevated fore-
arm venous plasma [NE] responses to the CPT in all trials, it is
clear that the CPT evoked sympathetic forearm vasoconstriction.
Second, in a separate time control experiment we confirmed that
the forearm vasoconstrictor response to CPT does not diminish
with a repeated CPT test. Third, robust functional sympatholysis
was observed during exercise, confirming the activation of these
mechanisms. Finally, andmost importantly, the reduction in FVC
in response to the CPT at 4min (PEearly) and 10min (PElate)
post-exercise was blunted compared to Rest. These observations
support the concept of a lingering functional sympatholysis effect
for as long as 10min following human skeletal muscle exercise at
15% below critical force.
THE USE OF THE CPT TO EVOKE INCREASED SYMPATHETIC
VASOCONSTRICTION
In this investigation, the CPT was a reliable methodological
approach for elevating forearm sympathetic vasoconstriction and
therefore allowing the assessment of functional sympatholysis.
The administration of the CPT resulted in repeatable elevations
of forearm deep venous plasma [NE] in all experimental con-
ditions and a robust forearm vasoconstriction at rest. Previous
evidence has also linked the use of the CPT with elevations in
venous plasma [NE]. Winer and Carter (1977) observed signif-
icant increases in plasma [NE] during hand immersion in ice
water that was linked to elevations inMAP andHR. Stratton et al.
(1983) also observed significant elevations in [NE] after 6min
of CPT administration as compared to rest. These observations
confirm the use of the CPT for elevating forearm vasoconstrictor
activity.
FUNCTIONAL SYMPATHOLYSIS DURING 15% BELOW fCF EXERCISE
In the present study, the administration of the CPT during Rest
resulted in a substantial reduction in FVC (−39.9 ± 6.1%), indi-
cating that sympathetically-mediated vasoconstriction is robust
at the skeletal muscle during resting periods. The mean percent
change in FVC due to the CPT during Exercise indicated that the
vasoconstrictor response appeared to be abolished at the skeletal
muscle during exercise at 15% below fCF.
These primary findings are in accordance with a wealth of liter-
ature demonstrating the presence of functional sympatholysis in
exercising muscle. This includes studies that specifically used CPT
to elevate sympathetic vasoconstriction. For example, Wray et al.
(2007) also utilized the CPT in their investigations into sympa-
thetic vasoconstriction during exercise in cyclists and sedentary
humans. Similar to the findings reported in this investigation,
they demonstrated a significant reduction in FVC during CPT
administration at rest (−38 ± 6%) which appeared abolished
during 50% maximal voluntary contraction handgrip exercise
(13 ± 11%). Differences between our study forearm exercise and
theirs were the use of isometric rather than dynamic exercise con-
tractions, a contraction force on average of ∼44% of MVC, and
a 1 s contraction to 2 s relaxation duty cycle compared to their
1:1 duty cycle. The latter two characteristics indicate the exercise
intensity in our study was therefore considerably less. In fact the
moderate increase in arterial blood pressure from rest to exer-
cise (see Table 3) and the lack of increase in forearm venous
effluent NE (see Figure 5) is consistent with a sustainable exer-
cise intensity we have used previously to investigate functional
sympatholysis (Tschakovsky et al., 2002).
Despite blunting of exercising muscle vasoconstriction, the
carotid baroreflex recruitment of exercising muscle sympathetic
restraint for the purpose of blood pressure regulation can occur
during exercise. This is evidenced by blood pressure elevation
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Table 3 | Absolute hemodynamic responses at all time-points during Trial B–E (see Figure 1).
Time (min) Exercise CPT protocol PEearly CPT protocol PElate CPT protocol
Exercise control trial Exercise CPT trial Exercise control trial PEearly CPT trial Exercise control trial PElate CPT trial
HEART RATE (bpm)
BLN 65.7±4.0 69.9±7.5 64.8±2.2 61.9± 1.9 64.7± 5.5 66.7±2.6
5 75.8±4.9 85.5±7.4 74.1±3.2 75.6± 2.9 69.9± 3.3 73.9±3.5
7 77.4±5.8 75.8±5.3 74.4±3.4 79.3± 2.6 70.9± 3.2 74.1±4.3
9 62.4±5.8 64.9±7.4 62.9±1.7 61.6± 2.0 64.7± 7.1 63.8±3.2
11 65.3±7.8 66.4±7.8 59.5±2.6 62.8± 3.4 59.3± 4.0 62.2±4.8
15 65.7±6.5 63.7±7.5 58.4±3.4 59.3± 2.7 61.3± 4.8 59.7±2.9
17 65.4±5.4 64.8±7.3 59.1±2.1 59.2± 2.3 61.6± 5.6 63.4±2.4
MEAN ARTERIAL PRESSURE (mmHg)
BLN 92.9±2.4 96.0±2.9 95.0±3.7 95.7± 3.0 91.4± 2.0 93.3±2.9
5 102.2±3.7 105.6±4.1 108.2±4.3 110.1± 3.2 105.1± 3.6 105.9±4.0
7 104.6±3.7 118.8±4.2 113.9±5.3 110.6± 3.1 106.1± 3.6 106.8±3.9
9 91.3±2.2 96.4±3.1 96.5±4.9 96.7± 2.2 93.6± 2.1 93.7±3.1
11 91.5±2.2 94.2±2.9 95.1±5.1 109.7± 3.1 90.5± 1.4 95.4±2.3
15 92.2±2.4 94.8±3.1 95.9±4.0 95.4± 2.8 91.3± 1.6 91.8±2.7
17 92.2±2.6 94.9±3.3 94.6±3.6 95.7± 2.2 90.7± 1.3 109.1±3.3
FOREARM BLOOD FLOW (ml/min)
BLN 30.7±4.4 34.3±5.3 39.2±5.2 37.5± 6.1 32.3± 5.0 45.3±12.0
5 376.6±39.7 365.5±28.9 471.0±65.0 464.8± 59.3 451.8± 67.2 411.9±62.4
7 427.4±48.2 420.5±27.3 520.7±73.7 506.6± 71.0 471.9± 84.9 469.8±64.6
9 169.4±42.6 153.0±37.9 213.0±52.6 205.7± 33.9 222.2± 39.0 188.6±37.7
11 112.2±29.4 99.4±24.9 146.2±41.9 100.7± 17.5 126.0± 29.9 121.5±23.0
15 78.4±17.7 57.4±10.5 87.0±24.6 79.8± 11.2 78.0± 18.7 65.4±8.6
17 67.0±16.0 51.9±9.8 75.6±17.7 68.4± 12.1 59.9± 10.2 54.4±6.5
FOREARM VASCULAR CONDUCTANCE (ml/min/100mmHg)
BLN 34.8±5.3 38.2±4.6 45.8±7.7 41.0± 6.2 35.3± 6.1 50.1±11.2
5 380.0±36.1 363.8±26.4 459.8±76.1 443.8± 65.3 436.2± 65.4 405.1±59.9
7 422.4±45.0 370.1±17.8 478.6±77.5 478.9± 72.0 452.7± 78.7 456.5±65.8
9 178.7±43.8 154.6±37.5 222.5±55.1 217.6± 34.9 233.2± 38.1 202.6±41.3
11 118.8±30.0 99.7±24.0 148.8±43.4 94.1± 16.1 133.0± 29.9 121.4±21.9
15 81.5±17.2 55.0±9.0 87.8±24.8 82.9± 12.0 79.9± 19.1 69.4±10.3
17 71.2±16.0 50.3±8.9 81.9±17.6 73.7± 16.4 62.8± 9.8 50.8±7.9
All data mean ± SE. BLN—Baseline rest prior to exercise onset. Exercise occurred from end BLN to end 7 min. Post-exercise period began at end of 7 min until
17 min. 5 min—pre-CPT in Exercise CPT Protocol; 7 min—post-CPT in Exercise CPT Protocol; 9 min—pre-CPT in PEearly CPT Protocol; 11 min—post-CPT in PEearly
CPT Protocol; 15 min—pre-CPT in PElate CPT Protocol; 17 min—post-CPT in PElate CPT Protocol. Gray shaded values represent the pre- and post-CPT within the
given CPT trial.
and exercising leg vasoconstriction in response to simulated
carotid hypotension via neck compression (Keller et al., 2004).
However, it must be noted that to date no studies have deter-
mined whether blood pressure regulation in response to an actual
hypotensive disturbance during exercise is adequately preserved.
In other words, whether functional sympatholysis can interfere
with blood pressure regulation in the face of sudden hypoten-
sion. Furthermore, impairment in blood pressure regulation in
response to a hypotensive disturbance might be even greater post-
exercise, where the muscle pump is not supporting central venous
filling pressure.
FUNCTIONAL SYMPATHOLYSIS POST-EXERCISE
We developed a new analysis approach to detect blunting of
sympathetic vasoconstriction during a non-steady state period
immediately following exercise. This technique has very good
predictive validity (curve fit estimation of FVC during the post-
exercise period closely matched actual FVC), and provides a new
research tool for understanding sympathetic vasoconstriction in
muscle post-exercise.
Themost important finding of the current study was that sym-
pathetic vasoconstriction remained significantly blunted in the
human forearm at both 4 and 10min post-exercise. The possi-
bility also existed for us to be able to assess whether the potency
of sympatholysis diminished over this time period. We would
hypothesize that over time, sympatholytic molecules like ATP,
NO, and H+ would diminish, and if they were responsible for
sympatholysis in the acute post-exercise period, the potency of
sympatholysis would diminish as well. Post-hoc analysis identi-
fied a P = 0.073 for PEearly vs. Exercise, and P = 0.052 for PElate
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FIGURE 4 | Central hemodynamic responses over the course of the
CPT during the resting trial on the PEearly and PElate experimental
days. Panel (A) mean arterial pressure (MAP). Panel (B) total peripheral
resistance (TPR). Panel (C) cardiac output (CO). ∗ indicates significantly
different from time 0 (baseline) for both PEearly and PElate P < 0.05.
FIGURE 5 | Catecholamine response to CPT in arterialized venous
blood at rest (Art. Rest), and deep forearm venous blood at rest,
exercise (Ex) early post-exercise (PEearly) and late post-exercise
(PElate). Panel (A) plasma epinephrine concentration. # indicates
significantly different from all other Pre-CPT forearm deep venous values,
P < 0.05. Panel (B) plasma norepinephrine concentration. ∗ indicates
End-CPT significantly different from corresponding Pre-CPT, P < 0.05.
vs. Exercise. Strictly speaking, failure to achieve P < 0.05 that is
set a priori requires we interpret the findings to suggest there was
not a diminished functional sympatholysis as much as 10min
post-exercise. However, given the sample size and variability in
the data, it is quite likely that this interpretation would represent
an incorrect failure to reject the null hypothesis.
An additional important consideration in this regard is
the possibility of individual differences in the time course
of sympatholytic molecule, and therefore sympatholysis, dis-
appearance. By 10min, three of eight subjects appeared to
have restored sympathetic vasoconstriction with CPT, while
five maintained robust sympatholysis. Group level data inter-
pretation may become problematic when there are appar-
ent individual differences in the time course of functional
sympatholysis decay. Follow-up investigations with a larger
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FIGURE 6 | Percent change in forearm vascular conductance (FVC) in
response to CPT. The response of each subject is identified with a unique
symbol. ∗ indicates significantly different from Rest, P < 0.05.
subject pool with repeated measures within each individ-
ual at multiple post-exercise assessment time points are nec-
essary to better determine the exact timeline of functional
sympatholysis decay post-exercise and its variation between
individuals.
Our findings in humans are consistent with those of
Howard and DiCarlo (1992) in rabbits, who observed a blunt-
ing of vasoconstriction in response to phenylephrine infusion
10min post-exercise compared to rest. This finding was later
replicated by the same group (Patil et al., 1993) who uti-
lized phenylephrine infusion and bouts of treadmill exercise
to examine alpha-adrenergic receptor-mediated vasoconstrictor
response post-exercise in Sprague–Dawley rats. In the exercise
trial, rats were infused with phenylephrine then ran on a treadmill
at 12–18 m/min at a 10–18% incline until exhaustion (mean =
45min). These investigators observed a blunted vasoconstric-
tor response to phenylephrine infusion at 6min post-exercise.
In addition, they examined the effect of nitric oxide synthase
(NOS)blockade and found that both at rest and after exercise,
this resulted in more robust vasoconstriction in response to
phenylephrine.
Whether nitric oxide is responsible for post-exercise sympa-
tholysis remains to be determined. Previous evidence suggests
a role for NO in the regulation of vasomotor tone following
skeletal muscle exercise. Radegran and Saltin (1999) investi-
gated the impact of NOS inhibition (via L-NMMA infusion)
on the femoral artery blood flow response following submax-
imal one-legged, dynamic knee-extensor exercise. Ten minutes
post-exercise, these investigators observed a significant reduc-
tion of 66 ± 5% in femoral artery blood flow during exercise
+ L-NMMA infusion as compared to exercise alone. Shoemaker
et al. (1997) found that brachial artery infusions of L-NMMA
also reduced post-exercise forearm blood flow following handgrip
exercise.
FIGURE 7 | Forearm vasoconstrictor response to CPT during repeated
trials at rest. CPT 1—first CPT test. CPT 2—second CPT test. Panel (A)
forearm vascular conductance (FVC) before (Pre-CPT) and at the end of
(End-CPT) a CPT. Panel (B) The difference in Pre- vs. End-CPT FVC
expressed as %change. ∗Main effect, significantly different from Pre-CPT,
P = 0.002.
Advantages and potential limitations
A critical characteristic of the present study was the inclusion
of time control experiments which confirm the reproducibility
of the CPT vasoconstrictor response with repeated trials. Since
the resting CPT trial was always performed before the exer-
cise or post-exercise CPT trials, the possibility existed that
blunted sympatho-excitation response to a second CPT could
explain the reduced vasoconstriction compared to rest. The
control experiments confirmed that this was not the case. We
observed no difference in the vasoconstrictor effect of CPT
across two trials that were separated by the amount of time that
occurred between rest CPT and the experimental post-exercise
CPT’s.
Another strength of the current study is that participants
were screened prior to recruitment in order to ensure that
only participants that would demonstrate sympathetic vasocon-
striction as the major component of their CPT response were
included in the study. Remembering that the CPT was merely
a tool to evoke sympatho-excitation and forearm vasoconstric-
tion, it was important to ensure that this tool did indeed evoke
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what it was intended to evoke. A lack of participant screen-
ing prior to investigation when utilizing the CPT could easily
lead to confounded conclusions due to the non-homogeneous
response to the CPT within a population (Ifuku et al., 2007;
Moriyama and Ifuku, 2007, 2010). Furthermore, we accounted
for normal changes in post-exercise blood flow by validation of
a curve fit prediction technique that provided good estimates
of what the normal FVC would have been during the CPT
test.
A potential limitation of the study is the inability to con-
clusively confirm that underlying MSNA was the same across
experimental conditions. In the current study, we wished to
determine whether post-exercise functional sympatholysis per-
sisted. For this reason, we chose a work rate that would maxi-
mize potential sympatholytic mechanisms during exercise so that
detection of their persistence post-exercise would be enhanced.
Additionally, in order to assess the effect of additional sympatho-
excitation during exercise, it was necessary for the exercise inten-
sity to result in a steady state. Given the problems with %MVC
representing a given relative metabolic intensity, (Kent-Braun
et al., 1993; Saugen et al., 1997) we identified an exercise inten-
sity of 15% below fCF, which maximizes the exercise intensity
while still safely ensuring the achievement of metabolic steady
state in exercise. An important consideration when interpret-
ing the responses to an imposed sympatho-excitation is the
potential confound of underlying MSNA levels. In other words,
is comparison of the effect of sympatho-excitation (1) at rest
vs. during exercise at 15% below fCF confounded by differ-
ent levels of underlying MSNA, and (2) at rest vs. post-exercise
confounded by withdrawal of exercise-evoked MSNA during
recovery?
In answer to the first issue: measurement of forearm venous
effluent [NE] (see Figure 5B) confirmed that there was no
increase in response to exercise. Yet there was a robust and
virtually identical increase in forearm venous effluent [NE] in
response to CPT at rest and during exercise. Finally, the exercise
intensity in this present study resulted in similar FVC and MAP
increases from rest to exercise as in our previously published work
which established the exercise intensity dependence of functional
sympatholysis in exercising human forearm (Tschakovsky et al.,
2002). Taken together, these findings support our interpretation
of robust functional sympatholysis during exercise at 15% below
fCF in the present study.
In answer to the second issue: it might be argued that
post-exercise withdrawal of any exercise-induced elevations in
MSNA could serve as a “passive” dilatory signal, explaining
the reduced vasoconstriction in response to CPT post-exercise.
For this to be the case, the post-exercise withdrawal of MSNA
would have to be occurring concomitant with the CPT stim-
ulation of MSNA, resulting in a net blunting of the increase
in MSNA. Arguing against this is the fact that already by the
time the early post-exercise CPT is initiated, HR and MAP have
returned to resting baseline levels, indicating a rapid return to
baseline of systemic sympatho-excitation. Furthermore, there is
no difference in the end-CPT forearm venous effluent [NE]
response in the rest vs. the two post-exercise CPTs. For all
in vivo studies of functional sympatholysis the basal MSNA upon
which a sympatho-excitatory stimulus is superimposed is not
known. Whether different basal MSNA affects the response to
CPT MSNA elevation is also not known. Therefore, as in all such
studies, the possibility that a difference in sympatho-excitation
evoked vasoconstriction between conditions is due to underly-
ing MSNA differences cannot be conclusively ruled out. In this
regard the present study is not different from previous work in
this area.
Finally, another potential limitation of the present study is
the n = 8 due to the loss of two subjects, which decreases
statistical power. In the case of the difference between rest-
ing and post-exercise %reduction in FVC, statistical significance
was reached. However, it is possible that for the catecholamine
analysis, specifically the epinephrine response, differences were
not detected due to lack of statistical power. It is also possible
that a failure to reject the null hypothesis in comparing func-
tional sympatholysis potency between exercise and post-exercise
conditions is due to a lack of statistical power.
Implications
This is the first study to confirm lingering functional sympa-
tholysis in human forearm muscle post-exercise. The implica-
tions of these findings must be considered within the context of
the subject selection criteria. These were young, healthy males
who demonstrated a vasoconstrictor response to CPT sympatho-
excitation. The data cannot be generalized to persons outside of
these criteria. Since sympatholysis during exercise occurs in both
upper (Tschakovsky et al., 2002; Wray et al., 2007) and lower limb
(Wray et al., 2007) exercise in humans, it is likely that sympathol-
ysis would linger post-lower limb exercise as well. The persistence
of functional sympatholysis following exercise with large muscle
mass holds significance for athletes and the modern day exercise-
enthusiast. Following an endurance exercise task, an athlete may
experience light-headedness. This is in part due to the relax-
ation of the muscle pump, which leads to a decline in venous
return and an acute reduction in filling pressure of the heart.
Combined with prolonged muscle vasodilation post-exercise, this
could ultimately result in syncope. Prevention of syncope via
baroreflex-mediated sympathetic vasoconstriction at a time when
CO increase may be limited would clearly be difficult due to the
prolonged blunting of vasoconstriction at the previously exercised
skeletal muscle.
Factors which impair blood pressure regulation in the face of
a hypotensive disturbance have serious implications for fighter
pilots (Scott et al., 2007). Because they complete full body con-
tractions in order to avoid gravity-induced loss of consciousness
(GLOC), the persistence of functional sympatholysis in the large
muscle mass used for this could be problematic during sub-
sequent mild +Gz maneuvers following these muscular efforts
where pilots may not engage in countermeasure contraction.
In this context, further research into the duration, magnitude,
and individual differences in post-exercise functional sympa-
tholysis is warranted. This would include determining whether
blood pressure regulation in response to +Gz is compromised
post-exercise.
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CONCLUSIONS
In conclusion, this study has demonstrated for the first time
in humans the existence of a lingering functional sympatholy-
sis in the first 10min following a bout of forearm exercise. This
may have important implications for blood pressure regulation
in the face of a hypotensive challenge. In this context, differences
between individuals in the duration that functional sympatholysis
is maintained post-exercise may also need to be considered.
ACKNOWLEDGMENTS
We would like to acknowledge the subjects for their
time and effort. Michael E. Tschakovsky was funded by
Natural Sciences and Engineering Council of Canada
(NSERC) Discovery Grant 250367-06, Canada Foundation
for Innovation and Ontario Innovation Trust Infrastructure
Grants, and a Queen’s University Chancellor’s Research
Award.
REFERENCES
Andersen, P., and Saltin, B. (1985).
Maximal perfusion of skeletal mus-
cle in man. J. Physiol. 366, 233–249.
Chavoshan, B., Sander, M., Sybert,
T. E., Hansen, J., Victor, R. G.,
and Thomas, G. D. (2002). Nitric
oxide-dependent modulation of
sympathetic neural control of
oxygenation in exercising human
skeletal muscle. J. Physiol. 540(Pt 1),
377–386.
Dinenno, F. A., and Joyner, M. J. (2004).
Combined NO and PG inhibition
augments alpha-adrenergic vaso-
constriction in contracting human
skeletal muscle. Am. J. Physiol. Heart
Circ. Physiol. 287, H2576–H2584.
doi: 10.1152/ajpheart.00621.2004
Dinenno, F. A., Masuki, S., and Joyner,
M. J. (2005). Impaired modulation
of sympathetic alpha-adrenergic
vasoconstriction in contracting
forearm muscle of ageing men.
J. Physiol. 567(Pt 1), 311–321. doi:
10.1113/jphysiol.2005.087668
Dishman, R. K., and Steinhardt, M.
(1988). Reliability and concurrent
validity for a 7-d re-call of physical
activity in college students.Med. Sci.
Sports Exerc. 20, 14–25.
Fadel, P. J., Farias, I. M., Gallagher,
K. M., Wang, Z., and Thomas, G.
D. (2012). Oxidative stress and
enhanced sympathetic vasocon-
striction in contracting muscles of
nitrate-tolerant rats and humans.
J. Physiol. 590(Pt 2), 395–407. doi:
10.1113/jphysiol.2011.218917
Gonzalez-Alonso, J., Olsen, D. B., and
Saltin, B. (2002). Erythrocyte and
the regulation of human skeletal
muscle blood flow and oxygen deliv-
ery: role of circulating ATP. Circ.
Res. 91, 1046–1055.
Halliwill, J. R., Dinenno, F. A., and
Dietz, N. M. (2003). Alpha-
adrenergic vascular responsiveness
during postexercise hypotension
in humans. J. Physiol. 550(Pt 1),
279–286. doi: 10.1113/jphysiol.
2003.042838
Halliwill, J. R., Taylor, J. A., and
Eckberg, D. L. (1996). Impaired
sympathetic vascular regulation in
humans after acute dynamic exer-
cise. J. Physiol. 495(Pt 1) 279–288.
Hansen, J., Sander, M., and Thomas,
G. D. (2000). Metabolic modula-
tion of sympathetic vasoconstric-
tion in exercising skeletal muscle.
Acta Physiol. Scand. 168, 489–503.
Howard, M. G., and DiCarlo, S. E.
(1992). Reduced vascular respon-
siveness after a single bout of
dynamic exercise in the con-
scious rabbit. J. Appl. Physiol. 73,
2662–2667.
Ifuku, H., Moriyama, K., Arai, K.,
and Shiraishi-Hichiwa, Y. (2007).
Regulation of cardiac function dur-
ing a cold pressor test in ath-
letes and untrained subjects. Eur.
J. Appl. Physiol. 101, 75–79. doi:
10.1007/s00421-007-0475-y
Ives, S. J., Andtbacka, R. H., Noyes,
R. D., Morgan, R. G., Gifford, J.,
Park, S. Y., et al. (2012). Alpha1-
adrenergic responsiveness in human
skeletal muscle feed arteries: the
impact of reducing extracellular pH.
Exp. Physiol. doi: 10.1113/expphys-
iol.2012.066613
Jones, A. M., Wilkerson, D. P.,
DiMenna, F., Fulford, J., and
Poole, D. C. (2008). Muscle
metabolic responses to exercise
above and below the “critical
power” assessed using 31P-MRS.
Am. J. Physiol. Regul. Integr. Comp.
Physiol. 294, R585–R593. doi:
10.1152/ajpregu.00731.2007
Joyner, M. J., Nauss, L. A., Warner,
M. A., and Warner, D. O. (1992).
Sympathetic modulation of blood
flow and O2 uptake in rhythmically
contracting human forearm mus-
cles. Am. J. Physiol. 263(4 Pt 2),
H1078–H1083.
Kellawan, J. M., Moylan, D., Nelson,
C., Bentley, R., and Tschakovsky,
M. E. (2010). Determining crit-
ical power in forearm handgrip
exercise: repeatability of a single
“all out” exercise test. Med. Sci.
Sports Exerc. 42, 573. doi: 10.1249/
01.MSS.0000385420.95815.2e
Keller, D. M., Fadel, P. J., Ogoh,
S., Brothers, R. M., Hawkins,
M., Olivencia-Yurvati, A., et al.
(2004). Carotid baroreflex
control of leg vasculature in
exercising and non-exercising
skeletal muscle in humans.
J. Physiol. 561(Pt 1), 283–293.
doi: 10.1113/jphysiol.2004.071944
Kent-Braun, J. A., Miller, R. G., and
Weiner, M. W. (1993). Phases of
metabolism during progressive
exercise to fatigue in human skele-
tal muscle. J. Appl. Physiol. 75,
573–580.
Kirby, B. S., Voyles, W. F., Carlson,
R. E., and Dinenno, F. A. (2008).
Graded sympatholytic effect of
exogenous ATP on postjunctional
alpha-adrenergic vasoconstriction
in the human forearm: impli-
cations for vascular control in
contracting muscle. J. Physiol.
586(Pt 17), 4305–4316. doi:
10.1113/jphysiol.2008.154252
Koskolou, M. D., Roach, R. C., Calbet,
J. A., Radegran, G., and Saltin, B.
(1997). Cardiovascular responses to
dynamic exercise with acute anemia
in humans. Am. J. Physiol. 273(4 Pt
2), H1787–H1793.
Moritani, T., Nagata, A., deVries, H.
A., and Muro, M. (1981). Critical
power as a measure of physical
work capacity and anaerobic thresh-
old. Ergonomics 24, 339–350. doi:
10.1080/00140138108924856
Moriyama, K., and Ifuku, H. (2007).
Assessment of cardiac contractility
during a cold pressor test by using
(dP/dt)/P of carotid artery pulses.
Eur. J. Appl. Physiol. 100, 185–191.
doi: 10.1007/s00421-007-0415-x
Moriyama, K., and Ifuku, H. (2010).
Increased cardiovascular reactivity
to the cold pressor test is not asso-
ciated with increased reactivity to
isometric handgrip exercise. Eur. J.
Appl. Physiol. 108, 837–843. doi:
10.1007/s00421-009-1299-8
Mortensen, S. P., Morkeberg, J.,
Thaning, P., Hellsten, Y., and
Saltin, B. (2012). Two weeks of
muscle immobilization impairs
functional sympatholysis but
increases exercise hyperemia and
the vasodilatory responsiveness to
infused ATP. Am. J. Physiol. Heart
Circ. Physiol. 302, H2074–H2082.
doi: 10.1152/ajpheart.01204.2011
O’Leary, D. S., Robinson, E. D., and
Butler, J. L. (1997). Is active skele-
tal muscle functionally vasocon-
stricted during dynamic exercise
in conscious dogs? Am. J. Physiol.
272(1 Pt 2), R386–R391.
Patil, R. D., DiCarlo, S. E., and
Collins, H. L. (1993). Acute exercise
enhances nitric oxide modulation
of vascular response to phenyle-
phrine. Am. J. Physiol. 265(4 Pt 2),
H1184–H1188.
Poole, D. C., Ward, S. A., Gardner,
G. W., and Whipp, B. J. (1988).
Metabolic and respiratory pro-
file of the upper limit for
prolonged exercise in man.
Ergonomics 31, 1265–1279. doi:
10.1080/00140138808966766
Pyke, K. E., Hartnett, J. A., and
Tschakovsky, M. E. (2008). Are
the dynamic response characteris-
tics of brachial artery flow-mediated
dilation sensitive to the magni-
tude of increase in shear stimulus?
J. Appl. Physiol. 105, 282–292. doi:
10.1152/japplphysiol.01190.2007
Radegran, G., and Saltin, B. (1999).
Nitric oxide in the regulation of
vasomotor tone in human skeletal
muscle. Am. J. Physiol. 276(6 Pt 2),
H1951–H1960.
Remensnyder, J. P., Mitchell, J. H., and
Sarnoff, S. J. (1962). Functional
sympatholysis during muscular
activity. Observations on influ-
ence of carotid sinus on oxygen
uptake. Circ. Res. 11, 370–380. doi:
10.1161/01.RES.11.3.370
Rosenmeier, J. B., Dinenno, F.
A., Fritzlar, S. J., and Joyner,
M. J. (2003). alpha1- and
alpha2-adrenergic vasoconstriction
is blunted in contracting human
muscle. J. Physiol. 547(Pt 3),
971–976. doi: 10.1113/jphysiol.
2002.037937





in human skeletal muscle.
J. Physiol. 558(Pt 1), 351–365.
doi: 10.1113/jphysiol.2004.063107
Rowell, L. B. (1997). Neural control
of muscle blood flow: importance
during dynamic exercise. Clin. Exp.
Pharmacol. Physiol. 24, 117–125.
Saltin, B., and Mortensen, S. P. (2012).
Inefficient functional sympatholysis
Frontiers in Physiology | Exercise Physiology June 2013 | Volume 4 | Article 131 | 14
Moynes et al. Post-exercise functional sympatholysis
is an overlooked cause of malperfu-
sion in contracting skeletal muscle.
J. Physiol. 590(Pt 24), 6269–6275.
doi: 10.1113/jphysiol.2012.241026
Saugen, E., Vollestad, N. K., Gibson,
H., Martin, P. A., and Edwards,
R. H. (1997). Dissociation between
metabolic and contractile responses
during intermittent isometric exer-
cise in man. Exp. Physiol. 82,
213–226.
Scott, J. M., Esch, B. T., Goodman, L.
S., Bredin, S. S., Haykowsky, M.
J., and Warburton, D. E. (2007).
Cardiovascular consequences of
high-performance aircraft maneu-
vers: implications for effective
countermeasures and laboratory-
based simulations. Appl. Physiol.
Nutr. Metab. 32, 332–339. doi:
10.1139/h06-087
Seals, D. R., and Victor, R. G. (1991).
Regulation of muscle sympathetic
nerve activity during exercise in
humans. Exerc. Sport Sci. Rev. 19,
313–349.
Shoemaker, J. K., Halliwill, J. R.,
Hughson, R. L., and Joyner, M.
J. (1997). Contributions of acetyl-
choline and nitric oxide to forearm
blood flow at exercise onset and
recovery. Am. J. Physiol. 273(5 Pt 2),
H2388–H2395.
Stratton, J. R., Halter, J. B., Hallstrom,
A. P., Caldwell, J. H., and Ritchie,
J. L. (1983). Comparative plasma
catecholamine and hemodynamic
responses to handgrip, cold pres-
sor and supine bicycle exercise test-
ing in normal subjects. J. Am. Coll.
Cardiol. 2, 93–104.
Taylor, C. B., Coffey, T., Berra, K.,
Iaffaldano, R., Casey, K., and
Haskell, W. L. (1984). Seven-day
activity and self-report compared
to a direct measure of physical
activity. Am. J. Epidemiol. 120,
818–824.
Thomas, G. D., and Victor, R. G.
(1998). Nitric oxide mediates
contraction-induced attenuation of
sympathetic vasoconstriction in rat
skeletal muscle. J. Physiol. 506(Pt 3),
817–826.
Tschakovsky, M. E., Sujirattanawimol,
K., Ruble, S. B., Valic, Z., and Joyner,
M. J. (2002). Is sympathetic neural
vasoconstriction blunted in the vas-
cular bed of exercising human mus-
cle? J. Physiol. 541(Pt 2), 623–635.
doi: 10.1113/jphysiol.2001.014431
Vanhatalo, A., Doust, J. H., and
Burnley, M. (2007). Determination
of critical power using a 3-min
all-out cycling test. Med. Sci.
Sports Exerc. 39, 548–555. doi:
10.1249/mss.0b013e31802dd3e6
Watanabe, H., Watanabe, K.,
Wadazumi, T., and Yoneyama,
F. (2007). Effect of exercise intensity
on mild rhythmic-handgrip-
exercise-induced functional
sympatholysis. J. Physiol. Anthropol.
26, 593–597.
Wiltshire, E. V., Poitras, V., Pak,
M., Hong, T., Rayner, J., and
Tschakovsky, M. E. (2010). Massage
impairs postexercise muscle blood
flow and “lactic acid” removal. Med.
Sci. Sports Exerc. 42, 1062–1071.
doi: 10.1249/MSS.0b013e3181c
9214f
Winer, N., and Carter, C. (1977).
Effect of cold pressor stimulation on
plasma norepinephrine, dopamine-
beta-hydroxylase, and renin activity.
Life Sci. 20, 887–893.
Woodman, R. J., Playford, D. A., Watts,
G. F., Cheetham, C., Reed, C.,
Taylor, R. R., et al. (2001). Improved
analysis of brachial artery ultra-
sound using a novel edge-detection
software system. J. Appl. Physiol. 91,
929–937.
Wray, D. W., Donato, A. J., Nishiyama,
S. K., and Richardson, R. S. (2007).
Acute sympathetic vasoconstric-
tion at rest and during dynamic
exercise in cyclists and sedentary
humans. J. Appl. Physiol. 102,
704–712. doi: 10.1152/japplphysiol.
00984.2006
Yegutkin, G. G., Samburski, S. S.,
Mortensen, S. P., Jalkanen, S.,
and Gonzalez-Alonso, J. (2007).
Intravascular ADP and soluble
nucleotidases contribute to acute
prothrombotic state during vigor-
ous exercise in humans. J. Physiol.
579(Pt 2), 553–564. doi: 10.1113/
jphysiol.2006.119453
Zavorsky, G. S., Lands, L. C.,
Schneider, W., and Carli, F. (2005).
Comparison of fingertip to arterial
blood samples at rest and during
exercise. Clin. J. Sport Med. 15,
263–270.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 01 September 2012; accepted:
18 May 2013; published online: 11 June
2013.
Citation: Moynes J, Bentley RF, Bravo
M, Kellawan JM and Tschakovsky ME
(2013) Persistence of functional sympa-
tholysis post-exercise in human skele-
tal muscle. Front. Physiol. 4:131. doi:
10.3389/fphys.2013.00131
This article was submitted to Frontiers
in Exercise Physiology, a specialty of
Frontiers in Physiology.
Copyright © 2013 Moynes, Bentley,
Bravo, Kellawan and Tschakovsky. This is
an open-access article distributed under
the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in other
forums, provided the original authors
and source are credited and subject to any
copyright notices concerning any third-
party graphics etc.
www.frontiersin.org June 2013 | Volume 4 | Article 131 | 15
